Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
BackgroundTo date, there has been no large-scale, real-world study of the health-related quality of life outcomes for patients using tumor treating fields (TTFields) therapy for glioblastoma (GBM) treatment.MethodsA survey was mailed to 2,815 patients actively using TTFields for treatment of GBM in...
Main Authors: | Joshua D. Palmer, Gordon Chavez, Wesley Furnback, Po-Ya Chuang, Bruce Wang, Christina Proescholdt, Chao-Hsiun Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.772261/full |
Similar Items
-
Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum–Based Chemotherapy Failure Setting
by: Yu Yang Soon, MBBS, et al.
Published: (2023-11-01) -
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
by: Denise Fabian, et al.
Published: (2019-02-01) -
Tumor treating fields: a new treatment for glioblastoma
by: Dimitar Slavkov, et al.
Published: (2023-12-01) -
Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging
by: Vikram S. Soni, et al.
Published: (2019-11-01) -
Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
by: Na Tosha N. Gatson, et al.
Published: (2021-05-01)